Azenta, Inc. (NASDAQ:AZTA) CFO Sells $28,529.84 in Stock

Azenta, Inc. (NASDAQ:AZTA) CFO Herman Cueto sold 712 shares of Azenta stock in a transaction dated Tuesday, November 19th. The stock was sold at an average price of $40.07, for a total transaction of $28,529.84. Following the transaction, the chief financial officer now directly owns 23,892 shares in the company, valued at $957,352.44. This trade represents a 2.89 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link.

Herman Cueto also recently made the following trade(s):

• On Thursday, October 17th, Herman Cueto sold 1,595 shares of Azenta stock. The shares were sold at an average price of $43.68, for a total transaction of $69,669.60.

Azenta Trading Up 2.0 %

AZTA traded up $0.88 on Thursday, hitting $45.53. 1,347,000 shares of the company were exchanged, compared to its average volume of 513,855. The firm has a 50-day moving average price of $45.32 and a two-hundred day moving average price of $50.22. Azenta, Inc. has a twelve month low of $38.82 and a twelve month high of $69.16.

Azenta (NASDAQ:AZTA) last released its quarterly earnings data on Tuesday, November 12th. The company reported $0.18 EPS for the quarter, beating analysts’ consensus estimates of $0.10 by $0.08. The business had revenue of $170.00 million for the quarter, compared to the consensus estimate of $169.66 million. Azenta had a positive return on equity of 1.03% and a negative net margin of 25.01%. The business’s revenue for the quarter was down 1.2% on a year-over-year basis. During the same quarter in the prior year, the business posted $0.13 EPS. Sell-side analysts expect that Azenta, Inc. will post 0.4 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Azenta

Several hedge funds have recently made changes to their positions in AZTA. Virtu Financial LLC acquired a new position in Azenta in the third quarter valued at $352,000. XTX Topco Ltd raised its stake in Azenta by 150.8% during the 3rd quarter. XTX Topco Ltd now owns 24,748 shares of the company’s stock valued at $1,199,000 after acquiring an additional 14,880 shares during the last quarter. Weiss Asset Management LP acquired a new stake in Azenta during the 3rd quarter worth approximately $1,726,000. State Street Corp grew its stake in shares of Azenta by 0.4% in the 3rd quarter. State Street Corp now owns 1,686,993 shares of the company’s stock valued at $81,718,000 after purchasing an additional 6,398 shares during the last quarter. Finally, Stifel Financial Corp raised its stake in shares of Azenta by 6.5% during the third quarter. Stifel Financial Corp now owns 59,241 shares of the company’s stock worth $2,870,000 after purchasing an additional 3,601 shares during the last quarter. Hedge funds and other institutional investors own 99.08% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts have commented on the company. Needham & Company LLC reduced their target price on Azenta from $69.00 to $55.00 and set a “buy” rating on the stock in a research report on Wednesday, November 13th. Evercore ISI decreased their target price on shares of Azenta from $53.00 to $50.00 and set an “in-line” rating on the stock in a research report on Tuesday, October 1st. Three equities research analysts have rated the stock with a hold rating and two have issued a buy rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Hold” and a consensus price target of $63.60.

Azenta Company Profile

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.